NYBC Ventures is an early-stage life sciences investment fund dedicated to advancing innovations in blood and cellular therapies. The fund invests in therapeutics, devices, and cutting-edge technologies that address critical challenges in these fields. Its mission is to improve patient outcomes by supporting groundbreaking therapeutics, platforms, and collaborative efforts.
Company Details
- Employees
- 9
- Founded
- 2022
- Address
- Critical Challenges In These Fields. Its Mission Is To Improve Patient Outcomes By Supporting Groundbreaking Therapeutics
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.nybcventures.com/
- Keywords
- New York.
Nybc Ventures Questions
Nybc Ventures's website is http://www.nybcventures.com/
Nybc Ventures's LinkedIn profile is https://www.linkedin.com/company/nybc-ventures
Nybc Ventures has
9 employees.
View email and phone details for 9
employees at Nybc Ventures.
Nybc Ventures's industry is
Venture Capital and Private Equity Principals
Nybc Ventures's top competitors are
F-Prime,
Novo Holdings,
Blackstone,
Eight Roads,
Vitestro,
The Dedham Group,
Sonder Capital,
Comprehensive Cell Solutions (Ccs),
New York Blood Center,
Agent Capital.
Nybc Ventures's categories are Venture Capital and Private Equity Principals
Nybc Ventures's founding year is 2022
